The difference in the tumour-to-contralateral ratio between HER2-positive (17.7 ± 9.54) and HER2-negative tumours (6.6 ± 2.7) was also significant (p = 0.0007, Mann–Whitney test) (Figure 4). Here, ERBB2 is linked to neoplasm.